Ecopia BioSciences Inc. (TSX:EIA) (“Ecopia” or the “Corporation”) and privately-held Caprion Pharmaceuticals Inc. (“Caprion”) are pleased to announce that, earlier today, their respective shareholders have approved the amalgamation of the two corporations, as part of a plan arrangement (“Arrangement”), to form a new corporation to be named Thallion Pharmaceuticals Inc. (“Thallion”), as well as the other transactions forming part of the Arrangement.
